½ÃÀ庸°í¼­
»óǰÄÚµå
1595137

»ê¼Ò¹ß»ý±â ½ÃÀå : À¯Çü, ±â¼ú, ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Oxygen Concentrators Market by Type (Portable, Stationary), Technology (Continuous Flow, Pulse Flow), End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 192 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»ê¼Ò¹ß»ý±â ½ÃÀåÀº 2023³â¿¡ 39¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 43¾ï 1,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 9.70%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 75¾ï 4,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

»ê¼Ò³óÃà±â´Â ÁÖº¯ °ø±â¿¡¼­ ³óÃàµÈ »ê¼Ò¸¦ ÃßÃâÇÏ¿© °ø±ÞÇÏ´Â ÀÇ·á±â±â·Î, ¸¸¼º ¹× ±Þ¼º È£Èí±â Áúȯ ȯÀÚÀÇ È£Èí Ä¡·á¿¡ ÇʼöÀûÀÎ ÀåºñÀÔ´Ï´Ù. ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), õ½Ä À¯º´·ü Áõ°¡¿Í ³ëÀÎ Àα¸ Áõ°¡·Î ÀÎÇØ ÀÌ·¯ÇÑ ÀåºñÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ½Ã¼³¿¡ ±¹ÇѵÇÁö ¾Ê°í ÀçÅÃÄ¡·á ȯ°æ, ±¸±ÞÂ÷, ±º µî¿¡µµ Àû¿ëµÇ¾î À¯¿¬ÇÑ »ê¼Ò ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â º´¿ø, Áø·á¼Ò, ÀçÅÃÄ¡·á ȯ°æ, Àå±â¿ä¾ç¼¾ÅÍ µîÀÔ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ÈÞ´ë¿ë ºñħ½ÀÀû ³óÃà±â ¸ðµ¨À» °¡Á®¿À´Â ±â¼ú ¹ßÀü, È£Èí±â ÁúȯÀÇ ¿øÀÎÀÌ µÇ´Â ¿À¿° ¼öÁØ Áõ°¡, Äڷγª19 ÀÌÈÄ È£Èí±â ÇÕº´Áõ¿¡ Å©°Ô ¿µÇâÀ» ¹Þ½À´Ï´Ù. Á¤ºÎÀÇ ÇコÄɾî ÀÌ´Ï¼ÅÆ¼ºê¿Í ¸¸¼º È£Èí±â Áúȯ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö¸é¼­ °³¹ßµµ»ó±¹ ¼ö¿ä Áõ°¡´Â »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº Ãʱâ Àåºñ ºñ¿ë, ³óÃÌ Áö¿ª¿¡¼­ÀÇ ³·Àº ÀÎÁöµµ, ¿ø°ÝÁö¿¡¼­ Àü±â¿¡ ÀÇÁ¸ÇÏ´Â ÀÛµ¿ ¾î·¹ÀÌÀÇ ¹°·ùÀû ¾î·Á¿ò µî ¿©·¯ °¡Áö ¹®Á¦Á¡ÀÌ ¿©ÀüÈ÷ ³²¾Æ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿Í ÀæÀº Á¦Ç° ¸®Äݵµ ¼ºÀå Àü¸ÁÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ÃÖ±Ù °¡Àå Å« ¹ßÀü°ú Çõ½Å ºÐ¾ß·Î´Â ÀåºñÀÇ È޴뼺 Çâ»ó, ½Ç½Ã°£ ¸ð´ÏÅ͸µ ¹× Çǵå¹éÀ» À§ÇÑ ½º¸¶Æ® ±â¼ú ÅëÇÕ, ¿ÀÇÁ ±×¸®µå »ç¿ë ¹× ¿¡³ÊÁö ºÎÁ· Áö¿ª¿¡¼­ÀÇ »ç¿ëÀ» ÃËÁøÇϱâ À§ÇÑ ¿¡³ÊÁö È¿À² °³¼± µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ÁÖ¿ä ±â¾÷µéÀÌ Á¦Ç° Æ÷Æ®Æú¸®¿À °­È­¿Í Àü·«Àû Á¦ÈÞ¿¡ ÁýÁßÇϸ鼭 Á¡ÁøÀûÀÎ ÅëÇÕÀÌ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ºñħ½ÀÀû ÀÀ¿ëÀ» À§ÇÑ »ýü Àç·á °³¹ß°ú °Ç°­ ¸ð´ÏÅ͸µÀ» À§ÇÑ AI ¶Ç´Â IoT ÅëÇÕ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿¬±¸´Â ¾÷°è¸¦ ¹ßÀü½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀ» °¨¾ÈÇÒ ¶§, Á¦Á¶¾÷üµéÀº º¸´Ù ±¤¹üÀ§ÇÑ ½ÃÀå ÁøÀÔÀ» À§ÇØ ºñ¿ë Àý°¨ Àü·«°ú Âü½ÅÇÑ Á¦Ç° º¯Çü¿¡ ÁýÁßÇØ¾ß Çϸç, ÀÌ´Â ¼±Áø±¹°ú ½ÅÈï±¹ ¸ðµÎ¿¡¼­ äÅÃÀ» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 39¾ï 4,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 43¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 75¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 9.70%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»ê¼Ò¹ß»ý±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼ºÁúȯÀ» ¾Î°í ÀÖ´Â Àü ¼¼°è ³ëÀÎ Àα¸ ±ÞÁõ
    • »ýȰ½À°üÀÇ º¯È­·Î ÀÎÇÑ È£Èí±â Áúȯ ¹ß»ý·ü Áõ°¡
    • ÀçÅà »ê¼Ò ¿ä¹ýÀ» ¼±È£Çϴ ȯÀÚ Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ ÁßÀú¼ÒµæÃþÀÌ Á¢±ÙÇÏ±â ¾î·Æ½À´Ï´Ù.
  • ½ÃÀå ±âȸ
    • º¸°ÇÀÇ·á½Ã¼³ °³¼±À» À§ÇÑ Á¤ºÎ¿Í Á¦Á¶¾÷üÀÇ Çù·Â°ü°è È®´ë
    • Á¦Ç° Æ÷Æ®Æú¸®¿À È®ÀåÀ» À§ÇÑ ÅõÀÚ Áõ°¡
  • ½ÃÀå °úÁ¦
    • ÇコÄÉ¾î ºÐ¾ßÀÇ Á¦Ç° ½ÂÀο¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥ ¹× Àúºñ¿ë ´ëüǰÀÇ °¡¿ë¼º

Portre's Five Forces: »ê¼Ò¹ß»ý±â ½ÃÀå Ž»öÀ» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »ê¼Ò¹ß»ý±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® »ê¼Ò¹ß»ý±â ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

»ê¼Ò¹ß»ý±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­, ÅëÇÕÀÇ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º »ê¼Ò¹ß»ý±â ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡/p>

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »ê¼Ò¹ß»ý±â ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ »ê¼Ò¹ß»ý±â ½ÃÀå¿¡¼­ ¼º°øÀÇ ±æÀ» ±×¸®´Ù.

»ê¼Ò¹ß»ý±â ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ ±â¾÷Àº °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ ü°è¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå »ê¼Ò¹ß»ý±â ½ÃÀå : À¯Çüº°

  • ÈÞ´ë¿ë
  • °ÅÄ¡Çü

Á¦7Àå »ê¼Ò¹ß»ý±â ½ÃÀå : ±â¼úº°

  • ¿¬¼Ó Ç÷οì
  • ÆÞ½º Ç÷οì

Á¦8Àå »ê¼Ò¹ß»ý±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) ¹× Áø·á¼Ò
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ »ê¼Ò¹ß»ý±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ »ê¼Ò¹ß»ý±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »ê¼Ò¹ß»ý±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • BPL Medical Technologies
  • CAIRE Inc.
  • Camozzi Automation S.p.A.
  • Chart Industries, Inc.
  • Drive DeVilbiss International
  • GCE Group
  • Inogen, Inc.
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Linde plc
  • NGK SPARK PLUG CO.,LTD
  • Nidek Medical Products Inc.
  • O2 Concepts, LLC
  • SMC Corporation of America
  • Supera Anesthesia Innovations
  • Teijin Limited
LSH

The Oxygen Concentrators Market was valued at USD 3.94 billion in 2023, expected to reach USD 4.31 billion in 2024, and is projected to grow at a CAGR of 9.70%, to USD 7.54 billion by 2030.

Oxygen concentrators are medical devices that extract and provide concentrated oxygen from ambient air, making them indispensable in respiratory care for patients with chronic or acute respiratory disorders. The growing necessity for these devices is underscored by the increasing prevalence of chronic obstructive pulmonary disease (COPD), asthma, and the rising geriatric population. Applications extend beyond healthcare facilities to include home healthcare settings, emergency transport, and military use, providing flexible oxygen solutions. Key end-users encompass hospitals, clinics, home care settings, and long-term care centers. Market growth is significantly influenced by technological advancements resulting in portable and non-invasive concentrator models, rising pollution levels contributing to respiratory ailments, and post-COVID-19 respiratory complications. There are emerging opportunities driven by the increasing demand in developing nations, supported by governmental healthcare initiatives and growing awareness of chronic respiratory disorders. However, challenges persist, notably the high initial cost of devices, lack of awareness in rural regions, and logistical difficulties in electricity-dependent operation arrays in remote areas. Furthermore, stringent regulatory frameworks and frequent product recalls can deter growth prospects. Recent advancements and best areas for innovation include enhancing device portability, integrating smart technologies for real-time monitoring and feedback, and improving energy efficiency to facilitate off-grid use or in energy-scarce locales. The market is characterized by moderate consolidation, with key players focusing on enhancing product portfolios and strategic collaborations. Continuous research in biomaterial development for non-invasive applications and AI or IoT integration for health monitoring can propel the industry forward. Given these factors, manufacturers need to focus on cost reduction strategies and novel product variants to tap into a broader market, potentially fostering accelerated adoption in both developed and emerging geographies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.94 billion
Estimated Year [2024] USD 4.31 billion
Forecast Year [2030] USD 7.54 billion
CAGR (%) 9.70%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Oxygen Concentrators Market

The Oxygen Concentrators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Surge in geriatric population with chronic conditions globally
    • Rising incidence of respiratory problems among population owing to changing lifestyles
    • Increasing penchant of patients toward home-based oxygen therapy
  • Market Restraints
    • High cost making them unaffordable for low and middle class economies
  • Market Opportunities
    • Increasing collaboration of manufacturers with government to improve healthcare facilities
    • Growing investment to expand product portfolio
  • Market Challenges
    • Stringent regulatory policies in healthcare sector for product approval and availability of low-cost alternatives

Porter's Five Forces: A Strategic Tool for Navigating the Oxygen Concentrators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Oxygen Concentrators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Oxygen Concentrators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Oxygen Concentrators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Oxygen Concentrators Market

A detailed market share analysis in the Oxygen Concentrators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Oxygen Concentrators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Oxygen Concentrators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Oxygen Concentrators Market

A strategic analysis of the Oxygen Concentrators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Oxygen Concentrators Market, highlighting leading vendors and their innovative profiles. These include BPL Medical Technologies, CAIRE Inc., Camozzi Automation S.p.A., Chart Industries, Inc., Drive DeVilbiss International, GCE Group, Inogen, Inc., Invacare Corporation, Koninklijke Philips N.V., Linde plc, NGK SPARK PLUG CO.,LTD, Nidek Medical Products Inc., O2 Concepts, LLC, SMC Corporation of America, Supera Anesthesia Innovations, and Teijin Limited.

Market Segmentation & Coverage

This research report categorizes the Oxygen Concentrators Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Portable and Stationary.
  • Based on Technology, market is studied across Continuous Flow and Pulse Flow.
  • Based on End User, market is studied across Ambulatory Surgical Centers & Physician Offices, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in geriatric population with chronic conditions globally
      • 5.1.1.2. Rising incidence of respiratory problems among population owing to changing lifestyles
      • 5.1.1.3. Increasing penchant of patients toward home-based oxygen therapy
    • 5.1.2. Restraints
      • 5.1.2.1. High cost making them unaffordable for low and middle class economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing collaboration of manufacturers with government to improve healthcare facilities
      • 5.1.3.2. Growing investment to expand product portfolio
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory policies in healthcare sector for product approval and availability of low-cost alternatives
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Oxygen Concentrators Market, by Type

  • 6.1. Introduction
  • 6.2. Portable
  • 6.3. Stationary

7. Oxygen Concentrators Market, by Technology

  • 7.1. Introduction
  • 7.2. Continuous Flow
  • 7.3. Pulse Flow

8. Oxygen Concentrators Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers & Physician Offices
  • 8.3. Home Care Settings
  • 8.4. Hospitals

9. Americas Oxygen Concentrators Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Oxygen Concentrators Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Oxygen Concentrators Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. BPL Medical Technologies
  • 2. CAIRE Inc.
  • 3. Camozzi Automation S.p.A.
  • 4. Chart Industries, Inc.
  • 5. Drive DeVilbiss International
  • 6. GCE Group
  • 7. Inogen, Inc.
  • 8. Invacare Corporation
  • 9. Koninklijke Philips N.V.
  • 10. Linde plc
  • 11. NGK SPARK PLUG CO.,LTD
  • 12. Nidek Medical Products Inc.
  • 13. O2 Concepts, LLC
  • 14. SMC Corporation of America
  • 15. Supera Anesthesia Innovations
  • 16. Teijin Limited
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦